Evaluation of Zinc in Patients With Type 2 Diabetes

NCT06751823 | Completed DMC

• 1 other identifier: MD-81-2024
• Study Type: observational
• Target: 195
• Locations: 1 country
• Sites: 1

Brief Summary

investigation of the impact of zinc level on the development of DM and to elaborate on whether daily consumption of zinc affects the disease's evolution.

Conditions

Type 2 Diabetes

Keywords

type 2 DM,; zinc

Outcome Measures

Primary Outcomes (4)

• zinc serum level in the participnats

  investigate the impact of zinc serum level on the development of DM

  "through study completion, an average of 1 year"

• Dietary micronutrient assessment using food questionnaire

  Dietary micronutrient assessment using food questionnaire adopted from a questionnaire for screening the micronutrient intake of economically active South African adults

  "through study completion, an average of 1 year"

• Trace elements daily intake calculation

  It will be calculated by multiplying the element contents measured in food (μg/kg) with the intake as estimated by the food micronutrient questionnaire (g/day).

  "through study completion, an average of 1 year"

• the dietary intake by kilogram (kg) of body weight (bw)

  the dietary intake by kilograms (kg) of body weight (bw) by dividing by the weight of participants.

  "through study completion, an average of 1 year"

Secondary Outcomes (1)

• HbA1C mesurements

  "through study completion, an average of 1 year"

Study Arms (2)

control

haelthy volunteers

Type 2 DM patients

patients of Type 2 DM with no known complications

Eligibility Criteria

• Age: 40 Years - 100 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

type 2 DM patients with no complication in comparison with health volunteers

You may qualify if:

• confirmed Type 2 DM with no known complication
• more than or equal 40 years old

You may not qualify if:

• pregnancy and lactation type 1DM known DM complication other endocrinological disorders malignancy

Sponsors & Collaborators

• Heliopolis University: lead

Study Sites (1)

Cairo University Hospitsl

Cairo, Egypt

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes Mellitus; Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• sara eladwy, lecturer

  Helioplis university

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: lecturer

Study Record Dates

• First Submitted: December 17, 2024
• First Posted: December 30, 2024
• Study Start: January 1, 2024
• Primary Completion: December 17, 2024
• Study Completion: December 17, 2024
• Last Updated: December 30, 2024

Record last verified: 2024-12

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)